Most Recent
Wavetrain drops bid to block Next Generation from talking about its IP
Intellectual Property 2019-02-25 2:24 pm By Cat Fredenburgh

Railway technology company Wavetrain Systems has dropped its bid for a court order barring a  competitor started by its former CEO from making allegedly false […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court
Intellectual Property 2019-02-25 1:34 pm By Cat Fredenburgh

The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Fisher & Paykel, ResMed lay down swords in global patent dispute
Intellectual Property 2019-02-22 1:00 pm By Cat Fredenburgh

New Zealand-based medical device maker Fisher & Paykel and US-based ResMed have agreed to resolve all disputes between them over patents for devices used to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

REA, Domain settle trade mark lawsuit over realestate.com redirect
Intellectual Property 2019-02-21 10:32 pm By Cat Fredenburgh

Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge lifts injunction won by State Street against Maurice Blackburn’s Fearless Girl
Intellectual Property 2019-02-21 9:53 pm By Christine Caulfield

Maurice Blackburn has persuaded a judge to lift a temporary injunction that blocked the law firm from going ahead with plans to unveil a replica […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Court to issue speedy ruling on Sanofi’s second stab at injector pen injunction
Intellectual Property 2019-02-20 9:48 pm By Cat Fredenburgh

The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Sandoz ordered to pay Lundbeck over $26.3M for infringing Lexapro patent
Intellectual Property 2019-02-19 10:18 pm By Christine Caulfield

Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Neurim wins fight to amend patent for top-selling Circadin amid infringement case
Intellectual Property 2019-02-19 7:35 pm By Christine Caulfield

Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Allergan snips Botox trade mark case against Self Care
Intellectual Property 2019-02-18 9:17 pm By Miklos Bolza

Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives. Allergan dropped its infringement claims […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Apotex, Cipla resolve claims over Dymista patent
Intellectual Property 2019-02-18 1:34 pm By Cat Fredenburgh

Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India’s Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista. In […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.